PQA elects 2026 board of directors and executive committee
PHIT CEO Jeff Rochon will serve as board chair.
PHIT CEO Jeff Rochon will serve as board chair.
Companion provides insights on partnerships for improving medication use quality.
The newly endorsed measure, Chronic Obstructive Pulmonary Disease Treatment Ratio (CTR), evaluates the percentage of individuals 40 years of age or older whose Chronic Obstructive Pulmonary Disease (COPD) Treatment Ratio (CTR) is least 70 percent during the treatment period.
Four new members from diverse health care professions, organizations and industries join board.
PQA Health Equity Technical Expert Panel recommendations inform measure testing, use in quality programs, and risk adjustment models.
Pilot will evaluate measure concepts and data exchange in value-based arrangements.